ArticleChemistry & biodiversity2026
Protective Effects of Duchesnea chrysantha Ethanol Extract Against UVB-Induced Skin Damage via Modulation of TAK1-Associated Signaling Pathways.
Article in Chemistry & biodiversity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Duchesnea chrysantha (Zoll. & Moritzi) Miq. (Rosaceae) has traditionally been used in East Asian medicine for inflammatory and skin-related disorders. This study investigated the phytochemical composition and protective effects of D. chrysantha ethanol extract (Dc-EE) against ultraviolet B (UVB)-induced skin damage. Untargeted LC-MS/MS analysis tentatively annotated various phytochemical constituents, including flavonoids and phenolic acids. Dc-EE reduced UVB-induced oxidative stress, reactive oxygen species production, and apoptosis in human keratinocytes (HaCaT) and dermal fibroblasts (HDF). It also suppressed cyclooxygenase-2 and matrix metalloproteinases (MMP-1, MMP-2, and MMP-9) in HaCaT cells while restoring collagen type I alpha 1 expression in HDF cells. In addition, Dc-EE enhanced the expression of skin barrier- and hydration-related factors, including filaggrin, transglutaminase-1, and hyaluronan synthase-2. Dc-EE attenuated UVB-induced MAPK signaling by reducing JNK, ERK, and p38 phosphorylation, together with AP-1 and NF-κB transcriptional activities. Reduced activation of transforming growth factor-β-activated kinase 1, an upstream stress-responsive regulator, was also observed. These findings indicate that Dc-EE attenuates UVB-induced cellular damage through antioxidant, anti-inflammatory, and barrier-related effects, supporting its potential for skin protection.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.